211 related articles for article (PubMed ID: 21756230)
1. Calcium metabolism & hypercalcemia in adults.
Lumachi F; Motta R; Cecchin D; Ave S; Camozzi V; Basso SM; Luisetto G
Curr Med Chem; 2011; 18(23):3529-36. PubMed ID: 21756230
[TBL] [Abstract][Full Text] [Related]
2. Calcium homeostasis and hyperparathyroidism: Nephrologic and endocrinologic points of view.
Lemoine S; Figueres L; Bacchetta J; Frey S; Dubourg L
Ann Endocrinol (Paris); 2022 Aug; 83(4):237-243. PubMed ID: 35598638
[TBL] [Abstract][Full Text] [Related]
3. Klotho gene, phosphocalcic metabolism, and survival in dialysis.
Torres PU; Prié D; Beck L; De Brauwere D; Leroy C; Friedlander G
J Ren Nutr; 2009 Jan; 19(1):50-6. PubMed ID: 19121771
[TBL] [Abstract][Full Text] [Related]
4. Electrolytes: Calcium Disorders.
Barstow C; Braun M
FP Essent; 2017 Aug; 459():29-34. PubMed ID: 28806048
[TBL] [Abstract][Full Text] [Related]
5. Hypercalcemia reduces plasma renin via parathyroid hormone, renal interstitial calcium, and the calcium-sensing receptor.
Atchison DK; Harding P; Beierwaltes WH
Hypertension; 2011 Oct; 58(4):604-10. PubMed ID: 21825222
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone and the regulation of renal tubular calcium transport.
Ko B
Curr Opin Nephrol Hypertens; 2017 Sep; 26(5):405-410. PubMed ID: 28614116
[TBL] [Abstract][Full Text] [Related]
7. Use of calcimimetics in children with normal kidney function.
VanSickle JS; Srivastava T; Alon US
Pediatr Nephrol; 2019 Mar; 34(3):413-422. PubMed ID: 29552709
[TBL] [Abstract][Full Text] [Related]
8. [Phosphocalcic metabolism: regulation and explorations].
Courbebaisse M; Souberbielle JC
Nephrol Ther; 2011 Apr; 7(2):118-38. PubMed ID: 21273150
[TBL] [Abstract][Full Text] [Related]
9. Disorders of calcium homeostasis.
Carmeliet G; Van Cromphaut S; Daci E; Maes C; Bouillon R
Best Pract Res Clin Endocrinol Metab; 2003 Dec; 17(4):529-46. PubMed ID: 14687587
[TBL] [Abstract][Full Text] [Related]
10. Overview of hypercalcemia of malignancy.
Solimando DA
Am J Health Syst Pharm; 2001 Nov; 58 Suppl 3():S4-7. PubMed ID: 11757205
[TBL] [Abstract][Full Text] [Related]
11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
12. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.
Torres PU
J Ren Nutr; 2006 Jul; 16(3):253-8. PubMed ID: 16825031
[TBL] [Abstract][Full Text] [Related]
13. Investigation of hypercalcemia.
Endres DB
Clin Biochem; 2012 Aug; 45(12):954-63. PubMed ID: 22569596
[TBL] [Abstract][Full Text] [Related]
14. Calcium and phosphate homeostasis: concerted interplay of new regulators.
Renkema KY; Alexander RT; Bindels RJ; Hoenderop JG
Ann Med; 2008; 40(2):82-91. PubMed ID: 18293139
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
[TBL] [Abstract][Full Text] [Related]
16. Tubular calcium reabsorption and other aspects of calcium homeostasis in primary and secondary hyperparathyroidism.
Phelps KR; Stote KS; Mason D
Clin Nephrol; 2014 Aug; 82(2):83-91. PubMed ID: 24985952
[TBL] [Abstract][Full Text] [Related]
17. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
18. Association of primary hyperparathyroidism and humoral hypercalcemia of malignancy in a patient with clear cell renal carcinoma.
Gomes Lda S; Kulak CA; Costa TM; Vasconcelos EC; Carvalho Md; Borba VZ
Arch Endocrinol Metab; 2015 Feb; 59(1):84-8. PubMed ID: 25926120
[TBL] [Abstract][Full Text] [Related]
19. Hypercalcemia due to constitutive activity of the parathyroid hormone (PTH)/PTH-related peptide receptor: comparison with primary hyperparathyroidism.
Parfitt AM; Schipani E; Rao DS; Kupin W; Han ZH; Jüppner H
J Clin Endocrinol Metab; 1996 Oct; 81(10):3584-8. PubMed ID: 8855805
[TBL] [Abstract][Full Text] [Related]
20. New insights on the pathogenesis of hypercalcemia in primary hyperparathyroidism.
Yonemura K; Suzuki H; Fujigaki Y; Hishida A
Am J Med Sci; 2000 Nov; 320(5):334-6. PubMed ID: 11093687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
